A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1)
Titel:
A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1)
Auteur:
Bonnefoi, H. Grellety, T. Tredan, O. Saghatchian, M. Dalenc, F. Mailliez, A. L'Haridon, T. Cottu, P. Abadie-Lacourtoisie, S. You, B. Mousseau, M. Dauba, J. Del Piano, F. Desmoulins, I. Coussy, F. Madranges, N. Grenier, J. Bidard, F.C. Proudhon, C. MacGrogan, G. Orsini, C. Pulido, M. Gonçalves, A.